RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Bristol-Myers Squibb Liabilities 2024

Bristol-Myers Squibb Liabilities

65.73 B USD

Bristol-Myers Squibb Dividend yield

5.08 %

Ticker

BMY

ISIN

US1101221083

WKN

850501

In 2024, Bristol-Myers Squibb's total liabilities amounted to 65.73 B USD, a -0.05% difference from the 65.76 B USD total liabilities in the previous year.

Bristol-Myers Squibb Aktienanalyse

What does Bristol-Myers Squibb do?

Bristol-Myers Squibb Co is a global biopharmaceutical company focused on the research, development, and production of prescription drugs and biosimilars for the treatment of serious diseases. The company is headquartered in New York, USA, and employs approximately 30,000 people worldwide. Bristol-Myers Squibb ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Bristol-Myers Squibb's Liabilities

Bristol-Myers Squibb's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Bristol-Myers Squibb's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Bristol-Myers Squibb's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Bristol-Myers Squibb's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Bristol-Myers Squibb’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Bristol-Myers Squibb Stock

What is the level of liabilities of Bristol-Myers Squibb this year?

Bristol-Myers Squibb has a debt balance of 65.73 B USD this year.

What were the liabilities of Bristol-Myers Squibb compared to the previous year?

The liabilities of Bristol-Myers Squibb have increased by -0.05% dropped compared to the previous year.

What are the consequences of high debt for investors of Bristol-Myers Squibb?

High liabilities can pose a risk for investors of Bristol-Myers Squibb, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Bristol-Myers Squibb?

Low liabilities mean that Bristol-Myers Squibb has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Bristol-Myers Squibb affect the company?

An increase in liabilities of Bristol-Myers Squibb can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Bristol-Myers Squibb affect the company?

A decrease in the liabilities of Bristol-Myers Squibb can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Bristol-Myers Squibb?

Some factors that can influence the liabilities of Bristol-Myers Squibb include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Bristol-Myers Squibb so important for investors?

The liabilities of Bristol-Myers Squibb are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Bristol-Myers Squibb take to modify the liabilities?

To change its liabilities, Bristol-Myers Squibb can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Bristol-Myers Squibb pay?

Over the past 12 months, Bristol-Myers Squibb paid a dividend of 2.28 USD . This corresponds to a dividend yield of about 5.08 %. For the coming 12 months, Bristol-Myers Squibb is expected to pay a dividend of 2.43 USD.

What is the dividend yield of Bristol-Myers Squibb?

The current dividend yield of Bristol-Myers Squibb is 5.08 %.

When does Bristol-Myers Squibb pay dividends?

Bristol-Myers Squibb pays a quarterly dividend. This is distributed in the months of August, November, February, May.

How secure is the dividend of Bristol-Myers Squibb?

Bristol-Myers Squibb paid dividends every year for the past 26 years.

What is the dividend of Bristol-Myers Squibb?

For the upcoming 12 months, dividends amounting to 2.43 USD are expected. This corresponds to a dividend yield of 5.42 %.

In which sector is Bristol-Myers Squibb located?

Bristol-Myers Squibb is assigned to the 'Health' sector.

Wann musste ich die Aktien von Bristol-Myers Squibb kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Bristol-Myers Squibb from 5/1/2024 amounting to 0.6 USD, you needed to have the stock in your portfolio before the ex-date on 4/4/2024.

When did Bristol-Myers Squibb pay the last dividend?

The last dividend was paid out on 5/1/2024.

What was the dividend of Bristol-Myers Squibb in the year 2023?

In the year 2023, Bristol-Myers Squibb distributed 2.16 USD as dividends.

In which currency does Bristol-Myers Squibb pay out the dividend?

The dividends of Bristol-Myers Squibb are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Bristol-Myers Squibb stock can be added to a savings plan with the following providers: Trade Republic, Scalable Capital and Consorsbank

Andere Kennzahlen von Bristol-Myers Squibb

Our stock analysis for Bristol-Myers Squibb Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Bristol-Myers Squibb Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.